By Type
By Treatment
Bend Use
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Pediatric Psoriasis Market Snapshot
Chapter 4. Global Pediatric Psoriasis Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type:
5.2.1. Plaque psoriasis
5.2.2. Guttate psoriasis
5.2.3. Pustular psoriasis
5.2.4. Inverse psoriasis
5.2.5. Erythrodermic psoriasis
5.2.6. Mucosal/oral psoriasis
5.2.7. Nail psoriasis
5.2.8. Napkin or diaper psoriasis
5.2.9. Photosensitive psoriasis
5.2.10. Flexural psoriasis
Chapter 6. Market Segmentation 2: by Treatment Estimates & Trend Analysis
6.1. by Treatment & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Treatment:
6.2.1. Topical therapy
6.2.2. Oral
6.2.3. Injections
6.2.4. Biologics
6.2.5. Natural supplements
6.2.6. Phototherapy
Chapter 7. Market Segmentation 3: by End-user Estimates & Trend Analysis
7.1. by End-user & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-user:
7.2.1. Hospitals
7.2.2. Specialty Clinics
7.2.3. Ambulatory Care Centers
7.2.4. Research Organizations
Chapter 8. Pediatric Psoriasis Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by Estimates and Forecasts by Type, 2021-2034
8.1.2. North America Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by Estimates and Forecasts by Treatment, 2021-2034
8.1.3. North America Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by End-user, 2021-2034
8.1.4. North America Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by Estimates and Forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by Type, 2021-2034
8.2.2. Europe Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by Treatment, 2021-2034
8.2.3. Europe Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by End-user, 2021-2034
8.2.4. Europe Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by Type, 2021-2034
8.3.2. Asia Pacific Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by Treatment, 2021-2034
8.3.3. Asia-Pacific Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by End-user, 2021-2034
8.3.4. Asia Pacific Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by Type, 2021-2034
8.4.2. Latin America Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by Treatment, 2021-2034
8.4.3. Latin America Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by End-user, 2021-2034
8.4.4. Latin America Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by Type, 2021-2034
8.5.2. Middle East & Africa Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by Treatment, 2021-2034
8.5.3. Middle East & Africa Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by End-user, 2021-2034
8.5.4. Middle East & Africa Pediatric Psoriasis Market Revenue (US$ Million) Estimates and Forecasts by by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. AbbVie Inc.
9.2.2. Amgen Inc
9.2.3. Johnson & Johnson
9.2.4. Novartis AG
9.2.5. Eli Lilly & Company
9.2.6. AstraZeneca
9.2.7. Celgene Corporation
9.2.8. UCB
9.2.9. Merck
9.2.10. Boehringer Ingelheim
9.2.11. LEO Pharma
9.2.12. Other Prominent Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.